Furthermore, a significantly decreased expression in miR-193b was observed in triple negative BC cell lines in comparison to non-triple negative and normal cells [67], in concordance with our findings that there was higher expression of miR-193 in luminal and HER-2+ BC cells. This evidence concerns the gene ERBB2 and breast cancer.